| Market Capitalization (Millions $) |
274 |
| Shares
Outstanding (Millions) |
25 |
| Employees |
40 |
| Revenues (TTM) (Millions $) |
4 |
| Net Income (TTM) (Millions $) |
-28 |
| Cash Flow (TTM) (Millions $) |
27 |
| Capital Exp. (TTM) (Millions $) |
7 |
Business Description
Movano Inc., a Delaware corporation, is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medtech and consumer devices. Our mission is to empower and inspire you to live a healthier, happier life.
The Company's proprietary platform uses Radio Frequency ('RF') technology, which we believe will enable the creation of low-cost and scalable sensors that are small enough to fit into wearable devices and other small form factors. Combined with our mobile app and cloud infrastructure, we expect that our platform will provide users with the ability to measure and continuously monitor vital health data and provide actionable feedback to jumpstart changes in behaviors.
The Company's platform is the foundation for its first product in development, the Movano Ring. The smart ring and its accompanying app will combine vital health metrics with personalized intelligent feedback and is designed for women of all ages, who are traditionally an afterthought when it comes to wearable technology. Once developed, we expect the Ring will measure heart rate, heart rate variability ('HRV'), sleep, respiration, temperature, blood oxygen saturation ('SpO2'), steps, calories and incorporate women-centric features and design. The device will provide users and their network of caregivers with health data distilled down to simple, yet meaningful, insights to help users make manageable lifestyle changes and take a more proactive approach to their health that could help mitigate the risks associated with chronic disease.
Our first planned product is currently in the development stage. For testing, we are using a full finger prototype and are currently shrinking the ring prototype to fit into a device similar to the one that is depicted in the image above. The ring prototype also has an optical sensor to estimate SpO2 measurements and an accelerometer to measure steps and calories.
We are also testing a wrist-worn wearable prototype that contains several proprietary ICs. Our proprietary integrated circuits in the wrist-worn prototype, which are supported by a radio-frequency technology platform, app and cloud infrastructure, allow us to calculate blood pressure, glucose, heart rate, and respiration rate estimates. In its current state, this prototype allows us to collect data, which we are using to generate glucose, blood pressure and heart rate estimates. The accuracy of the technology will be refined as our algorithms are improved and as we test larger cross sections of people in our external studies. We are currently in the process of shrinking the prototype.
Company Address: 6800 Koll Center Parkway Pleasanton 94566 CA
Company Phone Number: 651-3172 Stock Exchange / Ticker: NASDAQ MOVE
|
5.41% 
112.52 %